Body recomposition, gaining muscle while losing fat, is achievable and represents the optimal GLP-1 transformation outcome
Awareness of side effects and management
Clinicians can also support patients through continuing education around nutrition and lifestyle medicine fundamentals, like our new FIM course or these free online courses from the American College of Lifestyle Medicine
Start your journey with expert coaching, personalized nutrition, and real results, absolutely free for two weeks.
doi:10.1111/j.1365-2982.2010.01476.x Panjwani N, Mulvihill EE, Longuet C, et al
Key Products: Pemvidutide, balanced 1:1 dual GLP-1/glucagon receptor agonist, designed to drive both appetite suppression (GLP-1) and direct hepatic fat oxidation (glucagon)